Neoadjuvant Chemotherapy (NACT) in oral cancers shrinks the size of the tumor and makes it easy to resect. This intervention also allows mandibular preservation, thus sparing function. Therefore, NACT has promising outcomes for patients with oral cavity cancers. To get more insights on NACT, join expert oncologist Dr.
Jinesh R. Singhavi in an exclusive OncoTalks webinar on “ Neoadjuvant Chemotherapy in Oral Cavity Cancer ” on 4 th August 2022, 6:00 PM IST onwards. Chairperson – Dr. Uma Dangi Click to join!
